|
||
|
| Home |  |
Firm Description | |
Sectors Covered | |
Completed Transactions | |
Testimonials | |
Principals | |
M&A Report and Publications |
|
Contact Us | |
| Acquiring Party | Olympus Corp., a Japan-based large manufacturer of endoscopic equipment and other electronic and optical products. |
|---|---|
| Transferring Party | Gyrus Group Plc, a UK-based manufacturer of radio-frequency devices and energy-based technologies for minimally invasive surgical system. |
| Sector | Medical Devices |
| Date | November 19, 2007 |
| Analysis Helps solidify Olympus' capabilities in minimally invasive products. In 06, Olympus launched a strategic push to increase growth and earnings from the company's medical business. Olympus expects to expand its worldwide marketing network, particularly in urological and gynecological systems, in which Gyrus has an established presence in the U.S. market. Deal value -- $1.92b, on 06 sales of $425.8m (4.5x) and adj. EBITDA of $66.7m (28.8x). | |
The Walden Group is a leading healthcare investment banking firm specializing in mergers, acquisitions and strategic transactions. It also invests its own funds and, together with its expert operational partners, provides value-added services to help special companies reach critical milestones. This information is copyright © 2004-2007 The Walden Group, Inc. This information is provided as a service to the public but remains the intellectual property of The Walden Group, Inc and may not be reproduced in any manner without the written permission of The Walden Group, Inc. The information contained in the transactions table was derived from publicly available and other sources. Transaction analysis and other information are based, in part, upon public comments, Walden Group research and judgments, and reporting and research of others. The information is not intended to be relied upon as pronouncements by the transaction participants or for any other reason. | |